Skip to main content

Table 1 Characteristics of eligible non-diabetic patients aged ≥ 30 years with a known cardiovascular risk factor and impaired fasting glucose level (≥ 110-125 md/dl) by center and comparison group

From: Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy—the PVS-PREDIAPS strategy—to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial

 

Global group

Sequential group

 

PC1

N = 155

PC2

N = 456

PC3

N = 737

PC4

N = 278

Total

PC5

N = 228

PC6

N = 253

PC7

N = 665

PC8

N = 303

PC9

N = 188

Total

Age, mean (sd)

65.3 (13.7)

68.3 (12.5)

67.9 (12.2)

69.0 (11.6)

67.9 (12.4)

67.3 (13.5)

68.7 (13.2)

67.6 (13.2)

65.1 (12.4)

66.4 (12.6)

67.1 (13.0)

Women

n (%)

73 (47.1%)

252 (55.3%)

385 (52.2%)

138 (49.6%)

848 (52.1%)

116 (48.7%)

122 (48.2%)

336 (50.5%)

143 (47.2%)

93 (49.5%)

810 (49.2%)

BMI ≥ 25

n (%)

106 (68.4%)

286 (62.7%)

471 (63.9%)

177 (63.4%)

1040 (64.0%)

173 (72.7%)

166 (65.6%)

397 (59.7%)

231 (76.2%)

145 (77.1%)

1112 (67.5%)

BMI ≥ 30

n (%)

65 (41.9%)

190 (41.7%)

272 (36.9%)

101 (36.3%)

628 (38.6%)

114 (47.9%)

105 (41.5%)

230 (34.6%)

145 (47.8%)

94 (50%)

688 (41.8%)

SBP > 140

n (%)

61 (39.3%)

210 (46 %)

376 (51 %)

123 (44.2%)

770 (47.3%)

110 (46.2%)

131 (51.8%)

301 (45.3%)

143 (47.2%)

82 (43.6%)

767 (46.6%)

DBP > 90

n (%)

38 (24.5%)

38 (8.3%)

82 (11.1%)

38 (13.7%)

196 (12%)

29 (12.2%)

34 (13.4%)

104 (15.6%)

49 (16.2%)

25 (13.3%)

241 (14.6%)

Chol > 240

n (%)

28 (18.1%)

66 (14.5%)

156 (21.2%)

44 (15.8%)

294 (18.1%)

41 (17.3%)

36 (14.2%)

138 (20.7%)

50 (16.5%)

27 (14.4%)

292 (17.7%)

Tri > 200

n (%)

20 (12.9%)

65 (14.2%)

80 (10.9%)

46 (16.5%)

211 (13%)

48 (20.2%)

48 (19%)

78 (11.7%)

41 (13.5%)

28 (14.9%)

243 (14.7%)

Deprivation index

High

n (%)

142 (91.6%)

49 (10.7%)

140 (19%)

105 (37.8%)

436 (26.8%)

13 (5.5%)

32 (12.6%)

226 (34%)

133 (43.9%)

35 (18.6%)

439 (26.6%)

Medium

n (%)

9 (5.8%)

109 (23.9%)

219 (29.7%)

64 (23%)

401 (24.7%)

37 (15.5%)

65 (25.7%)

282 (42.4%)

96 (31.7%)

114 (60.6%)

594 (36.1%)

Low

n (%)

4 (2.6%)

298 (65.3%)

378 (51.3%)

109 (39.2%)

789 (48.5%)

188 (79%)

156 (61.7%)

157 (23.6%)

74 (24.4%)

39 (20.7%)

614 (37.3%)

Physical activity (PA)

A1_PA

n (%)

19 (12.3%)

46 (10.1%)

44 (6%)

31 (11.1%)

140 (9%)

25 (10.5%)

24 (9.5%)

41 (6.2%)

49 (16.2%)

47 (25%)

186 (11.3%)

A2_PA

n (%)

16 (10.3%)

28 (6.1%)

27 (3.7%)

25 (9%)

96 (5.9%)

21 (8.9%)

21 (8.2%)

23 (3.5%)

42 (13.9%)

42 (22.6%)

149 (9%)

A4_PA

n (%)

5 (3.2%)

5 (1.9%)

12 (1.6%)

5 (1.8%)

27 (1.7%)

7 (3.1%)

7 (2.8%)

3 (0.4%)

5 (1.6%)

6 (3.2%)

28 (1.7%)

Diet (DT)

A1_DT

n (%)

23 (14.8%)

66 (14.5%)

78 (10.6%)

33 (11.9%)

200 (12.3%)

35 (14.7%)

26 (10.3%)

70 (10.5%)

65 (21.4%)

53 (28.2%)

249 (15.1%)

A2_DT

n (%)

19 (12.3%)

52 (11.4%)

58 (7.9%)

27 (9.7%)

156 (9.6%)

29 (12.2%)

25 (9.9%)

48 (7.2%)

57 (18.8%)

43 (23.1%)

202 (12.3%)

A4_DT

n (%)

8 (5.2%)

28 (6.1%)

46 (6.2%)

15 (5.4%)

97 (6%)

12 (5.3%)

21 (8.3 %)

37 (5.6%)

37 (12.2%)

20 (10.6%)

127 (7.7%)

  1. Note: BMI, body mass index in kg/m2; Chol, cholesterol level in mg/dL; DBP, diastolic blood pressure in mmHg; SBP, systolic blood pressure in mmHg; Tri, triglyceride level in mg/dL